373P Quality-of-life outcomes in patients with HER2-positive, locally advanced or metastatic breast cancer treated with eribulin mesylate in combination with trastuzumab and pertuzumab in the phase III JBCRG-M06/EMERALD study
| Autor: | Masuda, N., Saji, S., Iwatani, T., Takano, T., Koizumi, K., Sagara, Y., Naito, Y., Tsuneizumi, M., Yoshimura, A., Takahashi, M., Tsurutani, J., Kitada, M., Tada, H., Higuchi, T., Kojima, Y., Kadoya, T., Hasegawa, H., Uchida, Y., Morita, S., Yamashita, T. |
|---|---|
| Zdroj: | In Annals of Oncology September 2024 35 Supplement 2:S375-S375 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|